Inputs
Customize Your Scenario
300
20%
$
LEP patients often have higher post-discharge risk
Driven by improved comprehension, adherence, and follow-up
$
ROI Calculator
See the Financial Impact of Closing the Post-Discharge Gap
Estimate the ROI of improving outcomes for high-risk patients — especially those impacted by language barriers.
— Adjust your inputs below —
20%
25%
Annual Cost Savings
$2,700,000
Based on 180 readmissions avoided per year across 720 patients with language barriers.
Readmissions avoided / year
180
Program cost / year
$360K
Net ROI
$2.3M
Savings per patient
$650
Readmission Cost: Before vs. After
Annual
$10.8M
Before
$8.1M
After
$2.7M
Savings
💡 Preventing just 1 readmission per ~30 patients offsets program cost.
Small Improvements. Significant Financial Impact.
Even modest improvements in comprehension, adherence, and follow-up compound across a discharge population — shifting avoidable utilization into measurable margin protection.
Where the ROI Comes From
Value creation comes from better patient understanding in the highest-risk window.
Reduced Readmissions
Avoid ~$15K+ per prevented readmission.
Improved Medication Adherence
Fewer complications and preventable escalations.
Higher Follow-Up Completion
Reduced ED revisits and downstream costs.
Before vs. After ETS
The difference between documented discharge and understood discharge.
Before ETS
Confused. Alone. At risk.
Discharge instructions don't translate.
- Discharge papers stay untranslated.
- Medication changes are misunderstood.
- Follow-up appointments are missed.
- Risk escalates without intervention.
After ETS
Engaged. Supported. At home.
Care that speaks their language.
- Instructions are reinforced in the patient's language.
- Medication questions are resolved quickly.
- Follow-up appointments are confirmed and completed.
- Care coordinators close loops before symptoms worsen.
- Patients feel supported, informed, and safe at home.
Pilot Program
Validate this in your system in as little as 90 days
Start with one high-risk population, measure avoided readmissions, and build the case for system-wide scale.